You have 9 free searches left this month | for more free features.

ORF15

Showing 1 - 25 of 53

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Patients With X-linked Retinitis Pigmentosa (XLRP)

Completed
  • X-Linked Retinitis Pigmentosa
    • Durham, North Carolina
    • +2 more
    Jan 10, 2023

    Achalasia Trial (ValACYclovir 1000 MG, Shingrix)

    Not yet recruiting
    • Achalasia
    • ValACYclovir 1000 MG
    • Shingrix
    • (no location specified)
    Jan 17, 2023

    Voices Of Individuals: Challenges and Experiences Of bvFTD

    Enrolling by invitation
    • Frontotemporal Dementia
    • +3 more
    • Telephone Interview
    • Baltimore, Maryland
    • +2 more
    Jan 10, 2023

    SARS-CoV-2 Infection Trial in Germany, United States (PRIME-2-CoV_Beta)

    Recruiting
    • SARS-CoV-2 Infection
    • Florida City, Florida
    • +6 more
    Jan 31, 2023

    COVID-19 Trial in Hohhot (Graphene spectrum light wave therapy room)

    Recruiting
    • COVID-19
    • Graphene spectrum light wave therapy room
    • Hohhot, Inner Mongolia, China
      Hohhot First Hospital
    Dec 7, 2022

    Amyotrophic Lateral Sclerosis Trial in Paris (Muscle biopsy)

    Active, not recruiting
    • Amyotrophic Lateral Sclerosis
    • Muscle biopsy
    • Paris, France
      Pitié-Salpêtrière Hospital
    Feb 17, 2022

    COVID-19 Trial in Tübingen, Hamburg (Prime-2-CoV_Beta)

    Recruiting
    • COVID-19
    • Prime-2-CoV_Beta
    • Tübingen, Baden-Württemberg, Germany
    • +1 more
    Jul 13, 2022

    Assistive Devices, Medicines and Healthcare Measures in ALS, SMA

    Recruiting
    • Amyotrophic Lateral Sclerosis
      • Berlin, Germany
      • +15 more
      May 2, 2023

      Novel Coronavirus Pneumonia Trial (Tanreqing capsule, Tanreqing capsule simulator)

      Not yet recruiting
      • Novel Coronavirus Pneumonia
      • Tanreqing capsule
      • Tanreqing capsule simulator
      • (no location specified)
      Apr 5, 2022

      Asymptomatic COVID-19 Trial in Shanghai (Cepharanthine, Placebo)

      Recruiting
      • Asymptomatic COVID-19
      • Shanghai, Shanghai, China
      • +1 more
      Jul 21, 2022

      Telemedicine, Pharynx, COVID-19 Trial in Olten (telemedically guided oropharyngeal + nasal (OP+N) self-sampling (GSS) and

      Active, not recruiting
      • Telemedicine
      • +2 more
      • telemedically guided oropharyngeal + nasal (OP+N) self-sampling (GSS) and nasopharyngeal (NP) or OP+N sampling performed by health care professionals (HCP)
      • Olten, Solothurn, Switzerland
        Teststation Praxis Dr. med Bielecki
      May 20, 2022

      A Study on a Blood-based Dual-target Test for CRC Detection

      Not yet recruiting
      • Colorectal Cancer
      • Colorectal Adenoma
      • Test of methylated NTMT1 and MAP3K14-AS1
      • FIT
      • (no location specified)
      Aug 20, 2022

      Cervical Cancer, Recurrent Cervical Cancer, Metastatic Cervical Cancer Trial in Mobile (Cabozantinib 40 MG oral once a day,

      Terminated
      • Cervical Cancer
      • +3 more
      • Cabozantinib 40 MG oral once a day
      • Pembrolizumab 200 mg IV every 3 weeks
      • Mobile, Alabama
        University of South Alabama Mitchell Cancer Institute
      Jun 3, 2022

      COVID-19, Influenza A, Influenza B Trial in Vienna (Panbio™)

      Recruiting
      • COVID-19
      • +2 more
      • Panbio™
      • Vienna, Virginia
        Advanced Pediatrics
      Nov 17, 2023

      Amyotrophic Lateral Sclerosis, Alzheimer, Mild Cognitive Impairment Trial in Fort Lauderdale, Boston (Baricitinib)

      Not yet recruiting
      • Amyotrophic Lateral Sclerosis
      • +2 more
      • Fort Lauderdale, Florida
      • +1 more
      Jan 25, 2022

      Tau Protein and SV2a Imaging in Tau Protein-related Diseases

      Recruiting
      • Alzheimer Disease
      • +2 more
        • Beijing, Beijing, China
          Xuanwu Hospital
        Feb 28, 2022

        Amyotrophic Lateral Sclerosis, Motor Neuron Disease Trial in France (biomarkers (composite analysis))

        Recruiting
        • Amyotrophic Lateral Sclerosis
        • Motor Neuron Disease
        • biomarkers (composite analysis)
        • Angers, France
        • +12 more
        Oct 5, 2021

        Amyotrophic Lateral Sclerosis Trial in Italy (Colchicine 1 MG Oral Tablet, Placebo Oral Tablet)

        Active, not recruiting
        • Amyotrophic Lateral Sclerosis
        • Colchicine 1 MG Oral Tablet
        • Placebo Oral Tablet
        • Bari, Italy
        • +9 more
        Aug 9, 2022

        COVID-19, Children Trial in Shanghai (Inhaled Interferon a2b, Standard of Care)

        Recruiting
        • COVID-19
        • Children
        • Inhaled Interferon α2b
        • Standard of Care
        • Shanghai, China
          Children Hospital of Fudan University
        May 18, 2022

        HFNC and NIV for COVID-19 Complicated by Respiratory Failure

        Completed
        • Respiratory Failure
        • HFNC
        • Hong Kong, Hong Kong
          Prince of Wales Hospital
        Jul 21, 2022

        Amyotrophic Lateral Sclerosis, Kennedy Disease Trial in Paris (Muscle biopsy)

        Not yet recruiting
        • Amyotrophic Lateral Sclerosis
        • Kennedy Disease
        • Muscle biopsy
        • Paris, France
          Pitié-Salpêtrière Hospital
        Oct 28, 2021

        Corona Virus Infection Trial in Rouen (ELISPOT)

        Recruiting
        • Corona Virus Infection
        • ELISPOT
        • Rouen, France
          Rouen University Hospital
        Jan 12, 2021

        Breast Cancer Trial in Shanghai (omit of IMI group, IMI group)

        Recruiting
        • Breast Cancer
        • omit of IMI group
        • IMI group
        • Shanghai, Shanghai, China
          Ruijin Hospital, Shanghai jiaotong univestigy school of medicine
        Mar 11, 2021

        Health Behavior, Health Care Utilization Trial in Eugene (Promotores de Salud, Services as usual)

        Recruiting
        • Health Behavior
        • Health Care Utilization
        • Promotores de Salud
        • Services as usual
        • Eugene, Oregon
          University of Oregon
        Jun 7, 2022

        Hepatitis E Infection Trial in Karachi (Hecolin® (Recombinant Hepatitis E Vaccine (Escherichia coli))., Isotonic Sodium Chloride

        Not yet recruiting
        • Hepatitis E Infection
        • Hecolin® (Recombinant Hepatitis E Vaccine (Escherichia coli)).
        • Isotonic Sodium Chloride injection
        • Karachi, Sindh, Pakistan
          The Aga Khan University
        Mar 29, 2023